BF Biosciences Limited (PSX:BFBIO)
Pakistan · Delayed Price · Currency is PKR 159.65
+1.90 (1.20%)
At close: Oct 21, 2025
BF Biosciences Revenue
In the fiscal year ending June 30, 2025, BF Biosciences had annual revenue of 5.84B PKR with 59.55% growth. BF Biosciences had revenue of 1.62B in the quarter ending June 30, 2025, with 118.44% growth.
Revenue
5.84B
Revenue Growth
+59.55%
P/S Ratio
2.40
Revenue / Employee
10.91M
Employees
535
Market Cap
14.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.84B | 2.18B | 59.55% |
| Jun 30, 2024 | 3.66B | 1.85B | 102.19% |
| Jun 30, 2023 | 1.81B | 288.82M | 18.99% |
| Jun 30, 2022 | 1.52B | -234.10M | -13.34% |
| Jun 30, 2021 | 1.75B | 1.13B | 179.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oil and Gas Development Company | 733.93B |
| Fauji Fertilizer Company | 466.71B |
| Lucky Cement | 449.63B |
| Oil and Gas Development Company | 401.18B |
| United Bank | 400.67B |
| Habib Bank | 340.65B |
| Meezan Bank | 298.05B |
| National Bank of Pakistan | 288.17B |